Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2005;64:798-800; doi:10.1136/ard.2005.039248
Copyright © 2005 BMJ Publishing Group Ltd & European League Against Rheumatism.
Annals of the Rheumatic Diseases 2005;64:798-800
© 2005 by BMJ Publishing Group Ltd & European League Against Rheumatism

LEADER

Antirheumatic treatment

The needle and the damage done*

J K Franz, G-R Burmester

Department of Rheumatology and Clinical Immunology, Charité University Hospital, Humboldt University of Berlin, Germany

Correspondence to:
Correspondence to:
Professor G-R Burmester
Department of Rheumatology and Clinical Immunology, Charité University Hospital, Humboldt University of Berlin, Schumannstr 20–21, D-10098 Berlin, Germany; gerd.burmester@charite.de


Evaluation of sublining macrophages by synovial needle biopsy, CD68 immunohistochemistry, and digital image analysis may help to establish evidence based treatments in RA.

Keywords: arthroscopy; biomarkers; macrophages; rheumatoid arthritis; synovial tissue; antirheumatic treatment

The first 150 words of the full text of this article appear below.

Despite decades of research, the aetiology of rheumatoid arthritis (RA) is still unknown. Early theories about its pathogenesis focused on autoantibodies and immune complexes, T cell mediated antigen-specific responses, a T cell independent cytokine network, and aggressive tumour-like behaviour of rheumatoid synovial tissue.1 Recently, B cell targeting approaches underline again the role of autoantibodies. None of these concepts alone could explain the chronic inflammation and progressive joint destruction characteristic of RA.

However, knowledge about the pathophysiological interplay of lymphocytes, macrophages, and local synovial fibroblasts within the synovial membrane has advanced over recent years. The success of treatments targeting tumour necrosis factor {alpha} (TNF{alpha}) and interleukin (IL) 1 suggest a key role for the monocyte-macrophage system in the pathophysiology of the disease. This is further supported by the fact, that macrophages are abundant within the rheumatoid synovial tissue.2 Moreover, both blood monocytes and tissue macrophages are activated and, in . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs